Showing results (911-920 of 1,206) with videos related to
Sort By:
Pageof 121
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.JACC. Cardiovascular Interventions|January 25, 2023
Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary SyndromeAntonio Landi, Mattia Branca, Sergio Leonardi, et al.American Heart Journal|February 10, 2016
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trialHolger Thiele, Steffen Desch, Jan J Piek, et al.Journal of the American College of Cardiology|July 17, 2010
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trialJoanna J Wykrzykowska, Scot Garg, Chrysafios Girasis, et al.Cardiology Journal|September 27, 2016
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trialMatteo Ghione, Joanna J Wykrzykowska, Stephan Windecker, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 11, 2021
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trialJaya Chandrasekhar, Samantha Sartori, Roxana Mehran, et al.Journal of the American College of Cardiology|May 23, 2025
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR PatientsDario Bongiovanni, Antonio Landi, Enrico Frigoli, et al.Heart (British Cardiac Society)|June 27, 2013
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers TrialRoberto Diletti, Hector M Garcia-Garcia, Christos V Bourantas, et al.Journal of the American College of Cardiology|February 21, 2019
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary SyndromeGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.Cardiology Research and Practice|October 26, 2018
Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI CohortsSlayman Obeid, Antonio H Frangieh, Lorenz Räber, et al.Pageof 121